An Efficacy and Safety Study of Hydromorphone Oral Osmotic System (OROS) in Korean Participants With Cancer Pain

NCT00766831 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

190

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer Pain

Interventions

DRUG: Hydromorphone

Sponsor

Janssen Korea, Ltd., Korea